SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-013207
Filing Date
2018-09-28
Accepted
2018-09-28 16:32:43
Documents
3
Period of Report
2018-09-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k092718_soligenixinc.htm 8-K 37200
2 CERTIFICATE OF AMENDMENT TO SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORA f8k092718ex3-1_soligenixinc.htm EX-3.1 9011
3 SOLIGENIX, INC. 2015 EQUITY INCENTIVE PLAN, AS AMENDED ON SEPTEMBER 27, 2018 f8k092718ex10-1_soligenixinc.htm EX-10.1 99933
  Complete submission text file 0001213900-18-013207.txt   147812
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 181094555
SIC: 2834 Pharmaceutical Preparations